We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Haloperidol Nitroso Impurity 1/N-Nitroso Haloperidol Impurity 1

Chemical Structure
Specifications
Product name
Haloperidol Nitroso Impurity 1/N-Nitroso Haloperidol Impurity 1
SRC CAT No
SRC-N014168
CAS No
3192-36-7
Mol.F.
C11H13ClN2O2
Mol.Wt.
240.7
Related CAS No.
NA
Inv Status
IN STOCK
Chemical Structure
Chemical Structure
view file icon VIEW COA

Chemical Name
4-(4-Chlorophenyl)-1-nitrosopiperidin-4-ol

HSN Code
38229010
Synonym
N.A

Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds . Haloperidol is used to treat nervous, emotional, and mental conditions (eg, schizophrenia). It is also used to control the symptoms of Tourette's disorder. This medicine should not be used to treat behavior problems in older adult patients who have dementia. Haloperidol Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.

Haloperidol Nitroso Impurity 1 CAS NO:3192-36-7 also known as N-Nitroso Haloperidol Impurity 1 chemically represented as 4-(4-Chlorophenyl)-1-nitrosopiperidin-4-ol .Synchemia is the leading manufacturing and exporter of Haloperidol Nitroso Impurity 1. We supply Haloperidol Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.